Presented at "Clinical Trials in Rare Diseases" 20240910_1515
presentation.mp4
Using AI methods to enable clinical trial success
Presented at "Clinical Trials in Rare Diseases" 20240910_1515
presentation.mp4
Using AI methods to enable clinical trial success
Presented at "Clinical Trials in Oncology West Coast Talk" Stream B Track 20240423_1300-1315
Using AI methods to enable clinical trial success
Presented at "Festival of Biologics" Clinical Trials Track "AI & Machine Learning for Trials" 20240416_1750-1810
Presented at "Festival of Biologics" Clinical Trials Track "Clinical Trial Planning & Design" 20240415_1710-1730
Presented at "Outsourcing in Clinical Trials West" on February 6, 2024
A Patient’s Approach to Innovative Clinical Research
Presented at at Sigma Xi's iFoRE - 20231110 9:00am
This is an incomplete list of US RCC expert oncologists recommended by our members, with a few international listings.
A few names are urologists centered on urologic oncology or kidney cancer. Many excellent urologic surgeons are not listed here because good urologists are much easier to find than expert RCC oncologists.
Dr. David Braun gave a nice summary of currwnt treatments and actual patient desires (Complete Response and Durability) at the 2023 ASCO this month in Chicago.
Here is the presentation.
ARPA-H is a new government organization created by Joe Biden. In their words:
The Advanced Research Projects Agency for Health (ARPA-H) supports transformative research to drive biomedical and health breakthroughs – ranging from molecular to societal – to provide transformative health solutions for all.
They are running two programs: DASH and BAA. Here is my Second Entry.
ARPA-H is a new government organization created by Joe Biden. In their words:
The Advanced Research Projects Agency for Health (ARPA-H) supports transformative research to drive biomedical and health breakthroughs – ranging from molecular to societal – to provide transformative health solutions for all.
They are running two programs: DASH and BAA. Here is my First Entry.